Acta Scientific Cancer Biology (ASCB) (ISSN: 2582-4473)

Case Review Volume 5 Issue 9

Looking for New Strategies for Gynecological Cancer

Margarita S Alfie1 and Adrian P Hunis2*

1Argentine Institute of Diagnosis and Treatment (IADT), Member of ASCO, Member of ESMO, Argentina
2School of Medicine, Universidad de Buenos Aires (UBA), Emeritus Member of ASCO, Argentina

*Corresponding Author: Adrian P Hunis, School of Medicine, Universidad de Buenos Aires (UBA), Emeritus Member of ASCO, Argentina.

Received: August 03, 2021; Published: August 19, 2021

Abstract

In order to achieve better results in survival, new strategies try to cover that need not meet in gynecological cancers.

At the ASCO Annual Meeting several works for ovarian cancer will be presented.

The Surgical treatment without residual disease is associated with better survival and prognosis. Additional strategies to achieve complete response were evaluated in the abstracts session.

Folate receptor α is overexpressed in a number of solid tumours, such as ovarian.

References

  1. https://meetings.asco.org/2021-asco-annual-meeting/13634?presentation=195542
  2. https://meetings.asco.org/2021-asco-annual-meeting/13634?presentation=195543
  3. https://meetings.asco.org/2021-asco-annual-meeting/13634?presentation=195539
  4. https://meetings.asco.org/2021-asco-annual-meeting/13634?presentation=195544
  5. https://meetings.asco.org/2021-asco-annual-meeting/13634?presentation=195547
  6. https://meetings.asco.org/2021-asco-annual-meeting/13668?presentation=196619
  7. https://meetings.asco.org/2021-asco-annual-meeting/13634?presentation=195541
  8. https://meetings.asco.org/2021-asco-annual-meeting/13634?presentation=195545
  9. https://meetings.asco.org/2021-asco-annual-meeting/13634?presentation=195552

Citation

Citation: Margarita S Alfie and Adrian P Hunis. “Looking for New Strategies for Gynecological Cancer". Acta Scientific Medical Sciences 5.9 (2021): 12-13 .

Copyright

Copyright: © 2021 Margarita S Alfie and Adrian P Hunis. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In




News and Events


Contact US